4‐Iodopyrimidine Labeling Reveals Nuclear Translocation and Nuclease Activity for Both MIF and MIF2**
|
journal
|
November 2021 |
D-dopachrome tautomerase is over-expressed in pancreatic ductal adenocarcinoma and acts cooperatively with macrophage migration inhibitory factor to promote cancer growth
|
journal
|
July 2016 |
Analysis of serum macrophage migration inhibitory factor and D‐dopachrome tautomerase in systemic sclerosis
|
journal
|
January 2018 |
Overview of the CCP 4 suite and current developments
|
journal
|
March 2011 |
Thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione Derivative Inhibits d-Dopachrome Tautomerase Activity and Suppresses the Proliferation of Non-Small Cell Lung Cancer Cells
|
journal
|
January 2022 |
Is There a Clinical Future for IDO1 Inhibitors After the Failure of Epacadostat in Melanoma?
|
journal
|
March 2020 |
Selective Targeting of a Disease-Related Conformational Isoform of Macrophage Migration Inhibitory Factor Ameliorates Inflammatory Conditions
|
journal
|
September 2015 |
Oxidized macrophage migration inhibitory factor is a potential new tissue marker and drug target in cancer
|
journal
|
September 2016 |
GROMACS: Fast, flexible, and free
|
journal
|
January 2005 |
MIF interacts with CXCR7 to promote receptor internalization, ERK1/2 and ZAP‐70 signaling, and lymphocyte chemotaxis
|
journal
|
July 2015 |
D-dopachrome tautomerase contributes to lung epithelial repair via atypical chemokine receptor 3-dependent Akt signaling
|
journal
|
June 2021 |
Structural and Kinetic Analyses of Macrophage Migration Inhibitory Factor Active Site Interactions
|
journal
|
December 2008 |
MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment
|
journal
|
April 2007 |
Structure of a trimeric domain of the MHC class II-associated chaperonin and targeting protein Ii
|
journal
|
December 1998 |
D‐dopachrome tautomerase in cardiovascular and inflammatory diseases—A new kid on the block or just another
MIF
?
|
journal
|
October 2022 |
How good are my data and what is the resolution?
|
journal
|
June 2013 |
GROMACS: High performance molecular simulations through multi-level parallelism from laptops to supercomputers
|
journal
|
September 2015 |
MIF but not MIF-2 recruits inflammatory macrophages in an experimental polymicrobial sepsis model
|
journal
|
December 2021 |
Differential regulation of macrophage activation by the MIF cytokine superfamily members MIF and MIF‐2 in adipose tissue during endotoxemia
|
journal
|
January 2020 |
CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields
|
journal
|
January 2009 |
A nuclease that mediates cell death induced by DNA damage and poly(ADP-ribose) polymerase-1
|
journal
|
October 2016 |
Redox-dependent structure and dynamics of macrophage migration inhibitory factor reveal sites of latent allostery
|
journal
|
June 2022 |
Structural Plasticity in the C-Terminal Region of Macrophage Migration Inhibitory Factor-2 Is Associated with an Induced Fit Mechanism for a Selective Inhibitor
|
journal
|
May 2018 |
An Analysis of MIF Structural Features that Control Functional Activation of CD74
|
journal
|
September 2015 |
Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast
|
journal
|
June 2010 |
XDS
|
journal
|
January 2010 |
CD44 Is the Signaling Component of the Macrophage Migration Inhibitory Factor-CD74 Receptor Complex
|
journal
|
October 2006 |
Structural basis for decreased induction of class IB PI3-kinases expression by MIF inhibitors
|
journal
|
September 2016 |
Generalized correlation for biomolecular dynamics
|
journal
|
December 2005 |
CHARMM36m: an improved force field for folded and intrinsically disordered proteins
|
journal
|
November 2016 |
Crystal structure at 2.6-A resolution of human macrophage migration inhibitory factor.
|
journal
|
May 1996 |
MolGpka: A Web Server for Small Molecule pKa Prediction Using a Graph-Convolutional Neural Network
|
journal
|
July 2021 |
Regulation of MIF Enzymatic Activity by an Allosteric Site at the Central Solvent Channel
|
journal
|
June 2020 |
The vestigial enzyme D-dopachrome tautomerase protects the heart against ischemic injury
|
journal
|
July 2014 |
D-dopachrome tautomerase (D-DT or MIF-2): Doubling the MIF cytokine family
|
journal
|
July 2012 |
Nanosecond Dynamics Regulate the MIF‐Induced Activity of CD74
|
journal
|
May 2018 |
Coot model-building tools for molecular graphics
|
journal
|
November 2004 |
MIF Signal Transduction Initiated by Binding to CD74
|
journal
|
June 2003 |
Macrophage CD74 contributes to MIF-induced pulmonary inflammation
|
journal
|
May 2009 |
A Cysteine Variant at an Allosteric Site Alters MIF Dynamics and Biological Function in Homo- and Heterotrimeric Assemblies
|
journal
|
February 2022 |
Removal of endotoxin from protein solutions by phase separation using triton X-114
|
journal
|
September 1990 |
REFMAC 5 for the refinement of macromolecular crystal structures
|
journal
|
March 2011 |
Macrophage migration inhibitory factor: a regulator of innate immunity
|
journal
|
October 2003 |
Coumarin and Chromen-4-one Analogues as Tautomerase Inhibitors of Macrophage Migration Inhibitory Factor: Discovery and X-ray Crystallography
|
journal
|
February 2001 |
The N-terminus of MIF regulates the dynamic profile of residues involved in CD74 activation
|
journal
|
September 2021 |
Macrophage migration inhibitory factor stimulates AMP-activated protein kinase in the ischaemic heart
|
journal
|
January 2008 |
The D-dopachrome tautomerase (DDT) gene product is a cytokine and functional homolog of macrophage migration inhibitory factor (MIF)
|
journal
|
August 2011 |
Molecular Cloning of Humand-Dopachrome Tautomerase cDNA: N-terminal Proline Is Essential for Enzyme Activation
|
journal
|
February 1998 |
Crystal Structure of Human d-Dopachrome Tautomerase, a Homologue of Macrophage Migration Inhibitory Factor, at 1.54 Å Resolution,
|
journal
|
February 1999 |
Molecular Profile of Peripheral Blood Mononuclear Cells from Patients with Rheumatoid Arthritis
|
journal
|
January 2007 |
Mechanism of a Reaction in Vitro Associated with Delayed-Type Hypersensitivity
|
journal
|
July 1966 |
A functional heteromeric MIF receptor formed by CD74 and CXCR4
|
journal
|
August 2009 |
The Tautomerase Active Site of Macrophage Migration Inhibitory Factor Is a Potential Target for Discovery of Novel Anti-inflammatory Agents
|
journal
|
July 2002 |
The Immunoregulatory Mediator Macrophage Migration Inhibitory Factor (MIF) Catalyzes a Tautomerization Reaction
|
journal
|
January 1996 |
MIF as a disease target: ISO-1 as a proof-of-concept therapeutic
|
journal
|
January 2011 |
A structurally preserved allosteric site in the MIF superfamily affects enzymatic activity and CD74 activation in D-dopachrome tautomerase
|
journal
|
September 2021 |
A Novel MIF Signaling Pathway Drives the Malignant Character of Pancreatic Cancer by Targeting NR3C2
|
journal
|
June 2016 |
VMD: Visual molecular dynamics
|
journal
|
February 1996 |
Targeting distinct tautomerase sites of D‐DT and MIF with a single molecule for inhibition of neutrophil lung recruitment
|
journal
|
July 2014 |
A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis
|
journal
|
May 2002 |
Interaction of pyridine-2,5-dicarboxylic acid with heavy metal ions in aqueous solutions
|
journal
|
January 2005 |
Human indoleamine 2,3-dioxygenase-2 has substrate specificity and inhibition characteristics distinct from those of indoleamine 2,3-dioxygenase-1
|
journal
|
May 2014 |